In hormone receptor status, the majority of HER2-negtive MBC patients were estrogen receptor (ER) positive and / or progesterone receptor (PR) positive, but the minority is patients with triple negative breast cancer. Here, ERBB2 is linked to triple-negative breast carcinoma.